99
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Formulation of rate-modulating pellets for the release of ibuprofen: An extrusion–spheronization process

, &
Pages 643-659 | Received 08 Nov 2004, Accepted 20 Apr 2005, Published online: 03 Oct 2008
 

Abstract

Purpose: To develop a stable and reproducible modified release pellet formulation containing ibuprofen.

Methods: Using extrusion–spheronization technology to produce pellets.

Results: The percentage yield, size distribution and overall pellet shape within the desired size range of 1000–1400 µm was found to be dependent on various process variables. These include extrusion and spheronization speed, spheronization time and composition of the granulation fluid. Formulation factors such as viscosity grade of hydroxypropylmethylcellulose and concentration of microcrystalline cellulose were shown to influence the drug release rate of the pellets. In vitro dissolution studies revealed that the pellets behaved in a pH-dependent manner. Pellets exposed to different drying techniques exhibited an increase in drug release rate in the order corresponding to oven-dried, vacuum-dried, fluid bed-dried and freeze-dried pellets. In conjunction with scanning electron microscopy, kinetic modelling and statistical treatment of dissolution data, it was confirmed that the predominant release rate-controlling mechanism was diffusion, as evidenced from the power law expressions incorporating Fickian and relaxational parameters (Mt /M = K1tn; Mt /M = K1tn + K2t2n). Matrix swelling and erosion were not significant factors in modulating the drug release rate.

Conclusions: The pH-dependent property of the pellets may be strategically employed towards development of a site-specific drug delivery system for non-steroidal anti-inflammatory agents. In general, targeting the delivery of an agent with potential for gastric irritation to the proximal intestine/colon may effectively reduce its ulcerogenic effect and ultimately contribute towards improved patient compliance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.